Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor Jul 26, 2021
Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations Jul 7, 2021
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space Jun 30, 2021
Can Psilocybin Treat Hyperphagia? Tryp Therapeutics’ Jim Gilligan & Dr. Jennifer Miller Want To Know May 3, 2021
